-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Evolent Health, Raises Price Target to $6

Benzinga·11/05/2026 21:40:17
Listen to the news
Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.